OBI Pharma Inc. to attend The 38th Annual J.P. Morgan Healthcare Conference

Announcement of the U.S. FDA approval on Orphan Drug Designation of Globo H antibody drug conjugate, OBI-999, targeting Pancreatic Cancer
December 24, 2019

1.Date of the event: Jan 16, 2020
2.Time: 05:30:00 NST
3.Location: Westin St. Francis Hotel, San Francisco, California
4.Summary: OBI Pharma Inc. to attend The 38th Annual J.P. Morgan Healthcare Conference
5.Any other matters that need to be specified: None

Please refer to MOPS for detail financial information regarding the event.